1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [578cc55a-5567-4488-b739-14f53d5c20c3] => Array
        (
            [runtime-id] => 578cc55a-5567-4488-b739-14f53d5c20c3
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [0b0d5592-a8d3-44ed-bf57-a69a16159d5d] => Array
                        (
                            [runtime-id] => 0b0d5592-a8d3-44ed-bf57-a69a16159d5d
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;5391bc73c9aee392aa4ae871d947a9cb3bccce2a
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [e7ea2003-92b1-4d0f-acd6-08160e79696f] => Array
        (
            [runtime-id] => e7ea2003-92b1-4d0f-acd6-08160e79696f
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [1f31ee78-82ec-4fc8-ad23-b0fefbd4181a] => Array
                        (
                            [runtime-id] => 1f31ee78-82ec-4fc8-ad23-b0fefbd4181a
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;5391bc73c9aee392aa4ae871d947a9cb3bccce2a
                )

        )

)
PT  - JOURNAL ARTICLE
AU  - Lee, W.-W.
AU  - Kim, J.-S.
AU  - Son, K.R.
AU  - Kwon, H.-M.
TI  - Atypical Diffusion-Restricted Lesion in 5-Fluorouracil Encephalopathy
AID  - 10.3174/ajnr.A2781
DP  - 2012 Aug 01
TA  - American Journal of Neuroradiology
PG  - E102--E103
VI  - 33
IP  - 7
4099  - http://www.ajnr.org/content/33/7/E102.short
4100  - http://www.ajnr.org/content/33/7/E102.full
SO  - Am. J. Neuroradiol.2012 Aug 01; 33
AB  - SUMMARY: Central nervous system toxicity of 5-FU could show various manifestations, such as decreased alertness, disorientation, and agitation. It is generally accepted that lesions of 5-FU encephalopathy are mainly in the deep cerebral white matter and corpus callosum on MR imaging. Here we describe a case of 5-FU encephalopathy in gastric cancer with an atypical reversible diffusion-restricted lesion on MR imaging, showing bilateral basal ganglia, thalami, and parasagittal frontal cortex involvement on diffusion and T2-weighted imaging. BUNblood urea nitrogenCRFchronic renal failureDPDdihydropyrimidine dehydrogenase5-FU5-fluorouracilPT/INRprothrombin time/international normalized ratio